Midas Pharma

Midas Pharma is a German pharmaceutical company founded in 1988.^[1] The company has 300 employees (as of 2023) and revenue of 550 million EUR (2023). Among other products,^[2] it makes a biosimilar for ranibizumab under brand name Ranivisio, approved in 2022 by EMA.^[3]

References

^ "History". www.midas-pharma.com. Retrieved 2024-09-04.
^ "Midas Pharma - discover our products". www.midas-pharma.com. Retrieved 2024-09-04.
^ "Ranivisio Authorization details". EMA.

External links

Official website

This German corporation or company article is a stub. You can help Wikipedia by expanding it.

[1] "History". www.midas-pharma.com. Retrieved 2024-09-04.

[2] "Midas Pharma - discover our products". www.midas-pharma.com. Retrieved 2024-09-04.

[emaref-3] "Ranivisio Authorization details". EMA.

[1]

[2]

[3]